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CHAPTER ONE
1.1 Introduction

Development theories all over the world has considered human capital as a major component for
economic growth and development both at micro and macro levels (Novignon & Lawanson, 2017;
Wilson & Briscoe, 2013). According to Grossman’s human capital model, investments in
education and health are significantly affects long run per capita income. Specifically, capital
development in health contributes to economic growth through the increase in healthy times for
both commercial and non-commercial activities (Novignon & Lawanson, 2017). Also, when
individuals are healthy, they have the capacity to make contributions towards the growth of a
nation, and four ways in which they can stimulate growth are: (i). at the place of work, healthier
individuals tend to be more productive and thus earn a higher income, (ii). they spend longer time
in the labour force and do not generally take sick leave or retire early, (iii). they have a higher
probability of investing in their own education and self-development, which in turn enhances
productivity and (iv). they are most likely to save and invest with the expectation of longer life
after retirement, this in turn increases the money available for investment within the economy
(Bloom & Canning, 1999, p. 1207). Therefore, improving the investment on healthcare remains
paramount in the development agenda of every nation, which is in line with the sustainable
development goal (SDG 3) of the United Nations (United Nations, 2020). Ensuring that everyone
lives healthy is critical to sustainable development, the recent global pandemic caused by the
COVID-19 is an example of how health crises can destabilize the economy and upend the lives of
people. Before, the emergence many low-and-middle income countries suffer from burden cases
like malaria and HIV/AIDS which has continually interrupted their daily lives and further reduced
their productivity. By the governments of these countries focusing on more efficient funding
towards the health systems, increasing the people’s access to physicians and improving the
sanitation and hygiene, there can be significant progress made in reducing events like infant and
maternal mortality (United Nations, 2020).

In the year 2000, 147 of 189 countries in the world, including the rich and poor countries, came
together at the Millennium Summit to make an unprecedent commitment in line with United
Nations millennium declaration to attain sustainable development and poverty eradication in a
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target fifteen years (15 years). This commitment was summarized into the Millennium
Development Goals (MDGs) targeted at improving human capital in the areas of poverty
alleviation, health development, education attainment, environmental sustainability, gender
equality and globalization. These MDGs were summarized into 8 goals which are: eradicate
poverty and extreme hunger, achieve universal primary education, promote gender equality and
empower women, reduce child mortality, improve maternal health, combat HIV/AIDS, malaria
and other diseases, ensure environment sustainability and to develop a global partnership for
development (WHO, 2005). To achieve this goal especially in health such as child mortality,
maternal health, combating HIV/AIDS and malaria adequate resources are needed. However, the
resources required for this development was limited in the Sub-Saharan African (SSA) region.

To this end, the African leaders gathered in the year 2001 in what is today known as the Abuja
Declaration, to offer an unprecedented commitment towards the improvement of health outcomes
in the continent by improving public health expenditure. The goal was to improve public health
expenditure to 15% of national budget by 2015. Till this day, only few countries in the continent
have been able to achieve this target. According to World Bank reports in 2012, only six (6)
countries had been able to achieve this target, these countries include: Rwanda (23%), Liberia
(18.9%), Malawi (18.5%), Madagascar (15.5%), Togo (15.4%) and Zambia (16%) (Novignon &
Lawanson, 2017). The economic giants within the continent like Nigeria, Ghana and South Africa
till this time are nowhere near this target. For instance, in the year 2013, public health expenditure
was only 3.39% of the total budget, while in Ghana it was 6.1% of the total budget (World Bank,
2019). Twelve (12) years after the MDG and eleven (11) years after the Abuja Declaration, the
WHO reported that only eight (8) countries were on track to meet the health related MDGs, most
of the countries within the region including Nigeria and Ghana were yet to achieve 50% of the
target (World Bank, 2019). The state of health in SSA is very poor, for instance Nigerian overall
health system performance was ranked 187th of 190 countries (WHO, 2017). In 2013 Nigeria’s
infant mortality rate was (80.5 per 1000 births) maternal mortality (951 per 100,000 deaths), and
Ghana (42 Per 1000 births) and (321 per 100,000 deaths) respectively are currently one of the
highest in the world when compared to other first world countries with single digits (World Bank,
2019). This study seeks to investigate how the effectiveness of public expenditure is affected by
public policy.
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Some studies have examined the relationship between public health expenditure and health
outcomes. For example, (Nixon & Ulmann, 2006) found that increasing public healthcare
expenditure is significantly associated with large improvements in infant mortality in fifteen
European Union (EU) countries between the years 1980 to 1995; evidence from (Crémieux et al.
1999) showed that lower healthcare spending is statistically significant to increase in in infant
mortality in Canada; and more recently, findings from Ojapinwa et al. (2012) revealed that public
health expenditure had a negative effect on infant mortality in Nigeria; and (Novignon &
Lawanson, 2017) found that public healthcare expenditure is positively and significantly related
to infant mortality, under-five mortality and neonatal mortality. Most of the above-mentioned
studies focused more on developed countries, except for (Novignon & Lawanson, 2017; Ojapinwa
& Yussuff, 1857) that paid attention to developing countries in their studies. In examining the
relationship between public health expenditure and health outcomes, all the studies examined by
this research restricted their health outcomes to mostly infant and maternal mortality. Deaths
caused by malaria and HIV are health outcomes of high prevalence in Sub Saharan Africa and
must not be overlooked hence, the reason for this study.

Based on this background, this study therefore examines the relationship between public health
expenditure and public health outcomes in Nigeria and Ghana, factoring the role of public policy.
Following the introduction of this research, the remaining aspects of this study is structured as
follow: literature review, theoretical and conceptual framework, methodology, findings,
discussion, implication and conclusion in section two, three, four, five, six and seven respectively.

1.2 Study Context

The context of this study is limited to two study areas located in Sub-Saharan African. The SubSaharan Africa region was considered because of the peculiar prevalence of health outcomes such
as infant mortality, maternal mortality, HIV/AIDS and malaria. According to reports from the
World Health Organization report (WHO, 2019), Africa accounts for 93% of the global malaria
cases, the region also accounts for the highest cases of HIV/AIDS, while infant and maternal
mortality still remain very high when compared to other regions of the world. Based on these
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reasons, two countries with high burdens of these outcomes were randomly selected for this study.
These countries are Nigeria and Ghana.

NIGERIA

Source: Umar Yusuf, 2018

Nigeria is a Sub-Saharan African country located in the West African region of the African
continent. Nigeria accounts for almost half of West Africa’s population with a population size
estimated around 202 million making largest African country in terms of population and one of
the highest population of youths in the world (World Bank, 2020). Nigeria is a multi-ethnic society
divided into six geopolitical zones as seen in the image above, namely: North-West, North-East,
North Central, South-East, South-South and South-West. Nigeria consists of 36 autonomous states
and the Federal Capital Territory (FCT), with seven hundred and seventy-four (774) local
government areas (LGAs). The country occupies a total land mass of 923, 763km2.

Nigeria has an abundance of natural resources such as tin, coal, limestone, iron ore and arable land
amongst many others. It is the largest exporter of crude oil in Africa and also has the largest natural
gas reserve on the continent (World Bank, 2020). The oil and gas sector accounts for almost ten
percent (10%) of the gross domestic product (GDP), the revenue from oil accounts for eighty-six
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percent (86%) of export revenue in Nigeria (OPEC, 2020). Despite the abundance of these
resources and huge revenue from crude oil, the impact of this has not reflected on the living
condition of the populace especially in the aspect of health.

According to recent reports from the World Bank, cases of Malaria and HIV/AIDS continues to
be public health burden in Nigeria. For instance, of the six countries that accounts for half of the
world’s malaria cases, Nigeria accounts for 25% of the total malaria burden (WHO, 2019). The
case of HIV/AIDS is also a prevalent public health problem within the country, according to
reports by the United Nations Aids (UNAIDS), HIV/AIDS affects 1.9million Nigerians (UNAIDS,
2020). It is for these reasons this study randomly selected Nigeria as one of its study areas.

GHANA

Source: William K Bosu

Ghana like Nigeria is a Sub-Saharan African country located in the Western region of Africa, the
country sits on the Atlantic Ocean bordering Togo, Ivory Coast and Burkina Faso. The country is
divided into nine (9) administrative regions namely: Northern, Volta, Central, Western, Eastern,
Ashanti, Brong-Ahafo, Upper West and Upper East regions. It has a population size of 29.6 million
people and a land mass of 238, 535 km2 (World Bank, 2020). Ghana is considered as one of the
stable economies in the West African region since its transition to a multi-party system.
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Ghana formerly known as the Gold Coast is rich in natural resources such as Gold, Cocoa and
most recently discovered oil which has recently formed the cornerstone of the booming economy.
In recent times, Ghana has experienced significant growth in its economy, for instance in 2019 the
gross domestic product experienced a growth of 6.7% and it’s projected to reach 7.6%. Oil, Gold
and Cocoa account for a significant share of the country’s export revenue, revenue from these three
exports resulted to a trade surplus of 2.8% of the country’s GDP (World Bank, 2020). Like Nigeria,
this economic success has not translated into a better health system. After twenty (20) years since
the Abuja Declaration and United Nations Millennium Development Goals commitment, the
country is yet to achieve 50% of the agreed targets.

Cases of Malaria, HIV/AIDS, infant and maternal mortality continues to threaten the lives of the
citizens. According to recent reports from the World Health Organization, 100% of Ghana’s
population are at risk of malaria infection, cases of infant and maternal mortality stand at 38.9 Per
1000 births in 2015 and 319 Per 100,000 deaths respectively in 2015 (WHO, 2019 and World
Bank, 2020). Despite these burdens public health expenditure when considered as a percentage of
the GDP has not experienced any significant shift from the early 2000s till this time. According to
the World Bank, public health expenditure grew by only 0.48% from 2000 till 2015 (World Bank,
2020). Based on these troubling issues Ghana was randomly selected as one of the two countries
to examined in this study.

1.3 Research Questions

This study aims to answer the following questions:
1.

What is the relationship between public health expenditure and health outcomes (infant
mortality, maternal mortality, malaria mortality and HIV/AIDS mortality) in Nigeria and
Ghana?

2.

How would the fulfilment of the United Nations general assembly commitment for the
MDGs (now known as the SDGs) and the Abuja Declaration affect health outcomes
between 2000 and 2018?

7

1.4 Research Hypothesis

The hypothesis of this study includes:

Hypothesis 1
•

Increase in public healthcare expenditure would improve health outcomes (infant mortality,
maternal mortality, malaria mortality and HIV/AIDS mortality).

Hypothesis 2
•

Public policy (Millennium Development Goals and Abuja Declaration) is significant to the
improvement of health outcomes in the region.
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CHAPTER TWO
LITERATURE REVIEW
Over the years, studies have examined the relationship between health expenditure and health
outcomes. On the micro level, an individual who is healthy will not only be more effective and
efficient at work, but he would devote more to other productive activities(Clements-Croome,
2015). Evidence from Straus and Thomas (1998), indicates that health status like other variables
such as education reflects the variations in wages. On the macro level studies of public health
expenditure and health outcomes globally have concentrated on three main themes: impact of per
capita income and health expenditure, total population outcome and health outcome, and health
aids and health outcome. Some studies have focused on the impact of per capita income on health
expenditure, for instance (Bloom & Canning, 1999; Marwa Farag, Nandakumar, & Stanley
Wallack, 2012; Jaunky & Khadaroo, 2008; Moscone, 2010; Murthy & Okunade, 2009). Some
other group of studies concentrated on estimating the relationship between health expenditure and
the total population health outcome (Babazono & Hillman, 1994; Bokhari, Gai, & Gottret, 2007;
Cevik, 2016; Novignon & Lawanson, 2017). The third group of more recent studies paid attention
to the relationship between health aid and health outcome (Claudia, 2008; Doucouliagos, 2019;
Yogo & Mallaye, 2015). Generally, this study has been considered from two separate angles of
developed and developing countries or high income and low- and middle-income countries.
However, the literature has reported conflicting views in the relationship between the public health
expenditure and health outcomes.

Based on the focus of this study, emphasis was placed on reviewing related literature focused on
developing countries especially the Sub-Sahara African region. The review suggests that there
exists to be an excessive number of studies that have focused on the relationship between health
expenditure and health outcomes in high income countries, with little focus on the low- and
middle-income countries (LMICs) or developing countries. Studies that have given attention to
developing countries with specific attention to the Sub-Sahara African region includes (Anyanwu
& Erhijakpor, 2009; Boachie, Ramu, & Tatjana, 2018; Gupta, Verhoeven, & Tiongson, 2002;
Gyimah-brempong & Wilson, 2004; Ojapinwa & Yussuff, 1857).
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Generally, research in this study area has revealed an inconsistent result in the relationship between
public health expenditure and health outcomes. Some studies for instance, (Filmer & Pritchett,
1997; Kim & Moody, 1992; Musgrove, 1996; Ojapinwa & Yussuff, 1857) revealed that there is
no relationship between health expenditure and health outcomes. (Musgrove, 1996) specifically
indicated that health expenditure has no impact on child mortality. More recently, results from
(Kamiya, 2010) showed that public expenditure did not have any impact of mortality in developing
countries.

In contrary to the above, results from other studies revealed a positive relationship between public
health expenditure and health outcomes, results from (Novignon & Lawanson, 2017) showed a
positive relationship between public health expenditure and health outcomes across forty-five SubSahara African countries. The study of (Novignon & Lawanson, 2017) examined this relationship
using variables such as infant mortality, under five mortality, crude death and life expectancy to
represent health outcomes. Results from (Anyanwu & Erhijakpor, 2009; Rahman & Khanam,
2014) indicate a positive relationship between public health expenditure and health outcomes.
Although in examining this relationship, (Anyanwu & Erhijakpor, 2009) only used to two variables
for health outcomes represented by infant mortality and under five mortality. Studies such as
(Bokhari et al., 2007; Crémieux et al., 1999; Gupta et al., 2002) found strong positive relationship
between public expenditure and infant mortality. Another interesting finding from the study of
(Bokhari et al., 2007) is that economic growth had a stronger relationship with health outcomes
and a more important contributor to the improvement of health outcomes in developing countries.
While result from (Filmer & Pritchett, 1997) show that although there is a positive link between
public health spending and health outcomes, the impact is statistically insignificant in both
developed and developing countries.

A more recent empirical studies by (M Farag et al., 2013) across 133 low and middle income
countries for a selected period of years 1995, 2000, 2005 and 2006 showed a significant impact of
public health spending on health outcomes. The study further explained that the magnitude of the
impact in this relationship was dependent on the levels of good governance. In other words,
countries with higher levels of good governance showed a higher significant impact of public
health spending on health outcomes. Although most of the results from high income countries
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reviewed by this study showed that there exist a stronger relationship between public health
spending and health outcomes, however, (Rana, Alam, & Gow, 2018) reported that the link
between public health expenditure is stronger for low income countries compared to higher income
countries. The result further explains that public health spending has an insignificant impact on
maternal mortality.

In a single country analysis (Nixon & Ulmann, 2006) was carried out by (Rhee, 2012) in South
Korea to examine the relationship between public health expenditure and infant mortality and life
expectancy at birth. The result shows that there was a positive relationship between public health
expenditure and health outcomes represented by the two selected variables of infant mortality and
life expectancy at birth. The study further concluded that in the long run public health expenditure
would be more impactful but in the short run, the number of physicians and hospital beds available
would impact more infant mortality and life expectancy at birth.

In a similar cross-country study of fifteen (15) European countries by (Nixon & Ulmann, 2006)
analyzed the relationship between public health expenditure and health outcomes similarly
represented by infant mortality and life expectancy. The result from this study revealed that there
is a positive relationship between public health expenditure and health outcomes however, public
health expenditure had no significant impact on life expectancy. In contrary to the findings by
(Nixon & Ulmann, 2006), result from (Cevik, 2016) show a strong negative relative relationship
between public health expenditure and health outcomes. The study by (Cevik, 2016) is a crosscountry analysis carried out across twenty countries, the variables used to represent health outcome
in this study were child and infant mortality. While the result was generally negative, there was
higher negativity between public expenditure and under-five mortality.

An important gap identified from previous literature is the fact most studies in both developed and
developing countries have only analyzed the relationship between health expenditure and health
outcomes using variables such as infant mortality, maternal mortality, life expectancy and life
expectancy at birth. However, other health outcomes such as Malaria and HIV/AIDS have not
been examined in this relationship. These two outcomes are high burden epidemics in developing
countries especially in Sub-Sahara African countries. Beyond individual illnesses and deaths
11

caused by Malaria and HIV/AIDS, these outcomes have undermined the social structure in SubSaharan African countries, evidence from other studies (Breman, Egan, & Keusch, 2001; Dixon,
McDonald, & Roberts, 2002; Arrow, Panosian, & Gelband, 2004 and Murphy et al., 2005) have
shown the social, financial and economic cost of malaria and HIV/AIDS related illnesses and
deaths. Secondly, only (Ojapinwa & Yussuff, 1857) has examined the role of governance in this
relationship. Based on review so far, no study has examined the relationship between public health
expenditure in Nigeria and Ghana combining these four variables (infant mortality, maternal
mortality, and malaria and HIV/AIDS mortality) together. This study will take it a step further by
examining the role of public policy in the relationship between public health expenditure and
health outcome, adding two other variables in Malaria and HIV/AIDS to infant and maternal
mortality.
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CHAPTER THREE
THEORETICAL AND CONCEPTUAL FRAMEWORK
3.1 Theoretical Framework

To explain the relationship between public health expenditure and health outcomes, this study
would utilize a demand side theory represented by Grossman’s demand for health model and a
supply side theory represented by Wagner’s Law. The Grossman’s demand for health model was
founded by Michael Grossman in 1972 in his monograph titled ‘The Demand for Health’ (Jones,
Rice, & Contoyannis, 2006). In this model, Grossman categorized health as a durable capital good
which has the potential to improve health outcomes. This model is considered the founding model
for the demand for health by (Jones et al., 2006). Wagner’s Law on the other hand postulates that
there is a positive relationship between economic growth and public expenditure. The theory was
propounded by a German economist known as Adolf Wagner, and first observed in Germany
before further observations in other parts of the world.
3.1.1 Demand Side Theory (Grossman’s Demand for Health Model)
Following the study of (Rana et al., 2018), this study would adopt the Grossman’s demand for
health model. Grossman’s demand for health model says that the gross investment on healthcare
comprises of four variables represented by medical care, time input and the stock of human capital.
I = (M, T, E)
From the above equation, gross investment is represented by I, medical care is represented by M
and the stock of human capital is represented by E.

Based on this model, a change in any of the given components would have an impact on the
outcome of healthcare in any society (Rana et al., 2018). In this model Grossman considered
medical as the most important component of gross investment on healthcare because, it is the most
marketable component of the three variables. Since medical care is the only marketable component
that is associated with price and cost, all other components in this model (time input and the stock
of human capital) were held constant. Based on that, a higher investment of medical care would
13

translate to an improved health status. Since this study argues that the increase in public health
expenditure would improve health outcome, this model would be relevant.
3.1.2 Supply Side Theory (Wagner’s Law)
Wagner’s law is generally known as the law of the of increasing government (state) spending, this
principle was named after Adolf Wagner, the German economist who propounded the law
(Wagner, 1890). This principle was first observed in Germany, following which Wagner tested in
other countries. The theory suggests that as the economy grows the share of public expenditure is
expected to also grow across the broad spectrum of the economy.
In 1994, (Ramakrishna, 2016) tested the validity of Wagner’s law in India, the study examined the
behaviour of government’s expenditure in relation to economic growth in India between 1960 and
1991. The study observed that the Wagnerian doctrine of rising public expenditure in relation to
economic growth was valid in the Indian context. Peacock and Wiseman also examined the
relationship between public expenditure and gross domestic product in the UK between 1891 and
1955, and Wagner’s theory was also found to be applicable (Henry & Olekalns, 2010). The study
observed that there was considerable increase in public expenditure in relation to economic
development, and the government cannot ignore the demands of the people for social services due
to an increasing revenue at constant tax rate.

Therefore, considering the peculiarity of this study areas, the study would also adopt the supply
side theory for this study. This is based on the assumption that there is an already existing demand
for health services because of the high prevalence of burden health cases such as infant mortality
and malaria mortality. However, state of medical centers, availability of drugs and equipment, and
the quality of service has prevented people from patronizing the healthcare centers while they rely
on self-medication. Hence, to improve the demand, the government must improve expenditure in
fixing the state of the healthcare centers. This study assumes that as the GDP grows, public health
expenditure (which will be represented as a percentage of gross domestic product) would also
increase, thus improving the health outcomes. As well, if there is a fall in the public health
expenditure, the level of health outcomes would also deepen.
14

3.2 Conceptual Framework

Globally, the concept of human capital development is an essential aspect of economic growth
(Abbas, 2010). According to the World Health Organization’s human development index (HDI),
health is considered a key component for human development, hence, investment in this sector is
critical (UNDP, 2019). Health is widely recognized as an input and also an outcome of
development processes (relationship between health and economic development), it is also
believed that upliftment in socioeconomic status would occur within the society as a result of an
improvement in health status (Abbas, 2010). Some studies (Fuentes, 2012; Karhan, 2019) have
identified human capital development as a factor that differentiates developed countries from
developing countries. This can be justified evidence that advanced education and health systems
translates to a better economy, and can be seen in countries like Germany, Sweden, Denmark and
other developed countries. Poor investment in important economic pillars like healthcare will lead
to poor health status in the population which will further lead to poor health outcomes. This should
be a reason for nations to reflect towards the development of social welfare policies that would
make the health sector a better place, and further translates into reductions in health outcomes.

Many African countries in comparison to developed countries in the west have lower investments
on health care, and also have higher health burden cases like high infant and maternal mortality,
more prevalent malaria cases and higher number of deaths from HIV/AIDS (World Health
Organization, 2011a). It is expected that increasing public health expenditure would be able to
improve these outcomes however, since the United Nations general assembly commitment towards
the achievement of the MDGs, currently known as the Sustainable Development Goals (SGDs),
and Abuja Declaration commitment in the years 1999 and 2000 respectively, policies have not
been put in place to stimulate the growth of public health expenditure. This study is adopting the
framework developed by (Abbas, 2010) to explain the role of public policy in the relationship
between public health expenditure and health outcomes.
Figure 3.0 Diagrammatic Relationship Between Public Health Expenditure and Health
Outcomes
Public Health Expenditure
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Source: Abbas, 2010

The above explanation in figure 3.0 reflects a supply and demand side scenario. (Abbas, 2010)
argues that the supply side is only hypothetical hence, hence the study examined this relationship
by analyzing only the demand side of this model (figure 3.0). The model assumes that from point
A, policies would be designed by the government to improve health status and outputs like fertility
rate, hospital services, nutrition and life expectancy thus the demand for healthcare would increase.
Since we operate most countries operate a market economy, an increase in demand for health
services would further increase supply which will be represented by public health expenditure.
Several studies for example, (Anyanwu & Erhijakpor, 2009; Rana et al., 2018) also used similar
analysis. Considering the selected study areas for this research, the demand for health care is very
high as a result of burden cases like malaria, infant and maternal mortality. Despite that, the public
health expenditure in the past decade has not had any significant increase (World Bank, 2020).
Hence, balancing both the demand and supply side analysis may yield a more positive outcome.
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CHAPTER FOUR
METHODOLOGY
4.1 Inclusion Criteria

Following standard evidence synthesis approach adopted by (Thomson et al., 2018) the inclusion
criteria for this study is considered as PICOS which stands for Population, Intervention,
Comparison, Outcome and Settings. In addition to the original adopted criteria, this study would
add a Study Period, which makes the inclusion criteria for this study PICOSS (Population,
Intervention Policies, Comparison, Outcome, Setting and Study Period).
1.

Population: The target group for this study would be children and mothers. These group of
the population were selected because, of the total affected cases of the burden cases in
developing country countries, they have been the most affected group. It is for this reason
this study has chosen to select health outcome variables in terms of infants and maternal
deaths.

2.

Intervention Policies: This study will include global and national public policies that affect
the health sector of the two study areas. Two of which include the Abuja Declaration and the
UN’s general assemble commitment towards the MDGs now known as the SDGs. These
interventions would be used to examine the role of public policies in the relationship between
public health expenditure and health outcomes.

3.

Comparison: This study will carry out a comparative analysis between two developing
countries in the Sub-Sahara African region. The two countries to be used in this study include
Nigeria and Ghana.

4.

Outcomes: The outcome for consideration in this study are health outcomes. Health
outcomes would be represented by the following dependent variables: infant mortality,
maternal mortality, malaria mortality, HIV/AIDS mortality. These variables are being
considered because of their high prevalence in the study areas. The afore mentioned
dependent variables would be examined against the public health expenditure, which will be
derived as a share of gross domestic product (GDP). The public healthcare expenditure will
serve as the independent variable for this study. Other variables such as the GDP, female
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school enrolment and urban population would be included as control variables for both
countries.
5.

Settings: The study will focus on the Sub-Sahara Africa region. Sub-Sahara African was
identified by this study because this region constitutes a large share of the global population
and coupled with this it suffers from a high prevalence of many burden health cases like
malaria and HIVAIDS. From this region, Nigeria and Ghana are the two specific study areas
considered for this study. These two countries were purposively selected for the following
reasons: the size of their economy, population risk, for instance 100% of the population in
Nigeria and Ghana are at risk of being infected by Malaria (WHO, 2014, 2017a, 2017b).
Based on those reasons, a comparative analysis of public health expenditure and health
outcomes in the context of developing countries, represented by Nigeria and Ghana.

6.

Study Period: The period under examination will be from 1999 to 2016. This study has
chosen this period because they represent significant events in the world that was channeled
to improve the global health. For example, in the year 2000 world leaders gathered at the
United Nations summit to commit towards the achieving global development. These
commitments were summarized what was known as the Millennium Development Goals
currently known as the Sustainable Development Goals (SDGs), one of the key areas of these
goals was health with targets such as reducing infant and maternal mortality, deaths caused
by malaria and HIV/AIDS (WHO, 2015; World Bank Group, 2020; World Health
Organization, 2014). Also, in 2001, the African leaders assembled in what is today known
as the Abuja declaration. In this meeting the African leaders committed to increasing public
health expenditure to 15% of their annual GDP by 2015. Hence, the decision of this study
period (World Health Organization, 2011b).

4.2 Data Collection, Participants and Procedure

The type of data to be used by this study are annual time series data from 2000 to 2018. This study
will collect quantitative data from key data sources like the World Bank data bank
(https://data.worldbank.org/),

World

Health

Organization

(https://www.who.int/gho/database/en/), the International Health Metrics Evaluation (IHME)
(http://www.healthdata.org/). The data collected will focus on health expenditure (public health
18

expenditure), the economy (gross domestic product, public expenditure) and health outcomes
(infant mortality, maternal mortality, malaria mortality and HIV/AIDS mortality). These variables
are in line with the goals of the MDGs and most recently the Sustainable Development Goal 3.0.
These sets of variables would be used to examine the relationship between public health
expenditure and health outcomes.

4.3 Data Analysis and Method

After the data collection, the study will employ the use of various techniques to analyze the
quantitative data. Descriptive statistics such as mean and standard deviations will be used as a
univariate technique to describe the data. Microsoft excel will be used to analyze the trends of the
independent and dependent variables. The independent variable would be represented by public
health expenditure which will be captured as a share of the GDP and the dependent variables would
be represented by the selected health outcomes for this study (infant and maternal mortality,
mortalities caused by malaria and HIV/AIDS).

Finally, SPSS will be used to carry out a linear regression analysis to examine the relationship and
effect of public health expenditure on health outcomes in both Nigeria and Ghana. The correlation
test would be carried out by examining the relationship between public health expenditure and
each dependent variable. The results from this would be compared between Nigeria and Ghana to
determine if there are any similarities between the two countries.

In this study, health outcomes were proxied by infant mortality, maternal mortality, and malaria
and HIV/AIDS morbidities. Health expenditure data is expressed as a share of the total
government’s expenditure for both countries. Following (Bokhari et al., 2007), it was observed
that since public health expenditure is potentially endogenous, there is a need to control for this
variable. Thus, the variables were controlled with GDP, female school enrolment and urban
population. This is because these variables are likely to be correlated with public health
expenditure.
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Figure 1: Trend of infant mortality rates in Nigeria and Ghana, 2000-2018
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The infant mortality rate (IMR), maternal mortality rate (MMR), malaria mortality (MM) and
HIV/AIDS mortality are represented in figure 1, 2, 3 and 4, respectively. Figure 1 shows that both
Nigeria and Ghana experienced a reducing trend in IMR from year 2000 to 2018. Ghana recorded
an average of 49.0 deaths per 1,000 live births (infant mortality), with Nigeria almost doubling
this figure with an average of 89.14 deaths per 1,000 live births over the same period. With respect
to maternal mortality rate, as seen in Figure 2, both countries experienced a downward trend over
the study period, but maternal mortality rates in these two countries remain relatively high.
Although when compared to Nigeria, Ghana reported a relatively low rate at an average of 357.9
per 100,000 deaths. Nigeria has an extremely high mortality rate with an average of 1025.37 per
100,000 deaths.

Figure 3 which shows the trend in malaria mortality in both Nigeria and Ghana shows an
interesting trend, with Ghana reporting a higher malaria death than Nigeria. The result shows that
Malaria caused an average of 133.9 and 113.5 deaths per 100,000 deaths in Ghana and Nigeria,
respectively. For HIV/AIDS mortality, which is shown in figure 4, displayed downward slopes
from 2008 with peak years for both countries in 2007 at 13% and 11.4% of total deaths for Nigeria
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and Ghana, respectively. However, Nigeria shows a slow downward trend from 12.8% in 2008 to
10.4 in 2018, while Ghana moved from 11.1% of total deaths share in 2008 to 6.5% in 2018.
Finally, figure 5 shows the trend analysis for public health expenditure per capita (PPP) for Nigeria
and Ghana. Although the graph showed an increasing trend, public health expenditure for countries
remains low at an average of 3.7% and 3.8% as a share of GDP respectively for both Nigeria and
Ghana. This indicates that the governments of both countries need to scale up health expenditure.

Figure 2: Trend of maternal mortality rates in Nigeria and Ghana 2000-2018
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Figure 3: Trend of Malaria mortality for Nigeria and Ghana 2000-2018
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Figure 4: Trend of HIV/AIDS in Nigeria and Ghana 2000-2018
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Figure 5: Trend of public health expenditure for Nigeria and Ghana, 2000-2018
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Table 1: Variable Names and Descriptive Statistics for Nigeria
Descriptive Statistics
Variables

Mean

Std. Deviation

N

HIV

11.6811

.95856

19

Malaria Mortality

108.7120

23.69364

19

Infant Mortality

89.1421

11.14711

19

Maternal Mortality

1025.368

102.22536

19

3.6879

.59178

19

4648.360

851.18954

19

86.4663

5.61767

19

42.5941

4.88960

19

4
Public
Expenditure

Health
as

a

Percentage of GDP
GDP

6
Female

School

Enrolment
Urban Population
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Table 2: Variable names and descriptive statistics for Ghana
Descriptive Statistics
Variables

Mean

Std. Deviation

N

HIV/AIDS Mortality

9.6507

1.68288

19

Malaria Mortality

127.6273

30.31067

19

Infant Mortality

49.0263

9.23796

19

Maternal Mortality

357.8947

48.23426

19

Public

3.7657

.68932

19

3075.159

685.90540

19

94.5877

12.39512

19

50.0201

3.80615

19

Expenditure

Health
as

a

Percentage of GDP
GDP

3
Female

School

Enrolment
Urban Population

Summary descriptive statistics of the variables used in the empirical analysis for Nigeria and
Ghana are available in table 1 and 2, respectively. The tables show that, on the average (mean),
infant mortality stood at 89.14 per 1,000 births for Nigeria and 49.03 for Ghana. Maternal
Mortality mean was 1025 and 357.9 per 100,000 deaths for Nigeria and Ghana, respectively. The
mean for malaria mortality was 108.7 per 100,000 deaths for Nigeria and 127. 6 per 100,000 deaths
for Ghana. The mean for HIV/AIDS for Nigeria and Ghana were 11.68% and 9.65% respectively.
The other variables found in the table are the control variables represented by GDP, urban
population, and female school enrolment.
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4.4 Findings and Discussion
Table 3: Public Health Expenditure and HIV/AIDS for Ghana and Nigeria
Variables

Ghana
(1) (2)

HIV/AIDS

-.059

Nigeria
(3)

(4)

(5)

-.917

-.854

-.854

.423

.423

.981

.981

(1)

(2)

(3)

(4)

(5)

.323

.201

.201

.015

.201

.201

-.090

-.329

.950

Mortality
Public
Health

.364

Expenditure
GDP
Female

.924

-.493

School
Enrolment
Urban
Population

Table 4: Simulation for Public Health Expenditure and HIV/AIDS Mortality for Ghana and
Nigeria
Variables

Ghana
(1)

HIV/AIDS
Mortality

Nigeria

(2)

(3)

(4)

(5)

-.866

-.917

-.710

-.854

.983

.918

1.000

.899

.981

(1)

(2)

(3)

(4)

(5)

-.006

.242

.201

.015

.942

-.501

1.000

-.329

.950

Public
Health
Expenditure
GDP
Female
School

.924

Enrolment
Urban
Population
25

-.493

Table 5: Public Health Expenditure and Malaria Mortality for Ghana and Nigeria
Variables

Ghana
(1)

Malaria
Mortality

Nigeria

(2)

(3)

(4)

(5)

-.063

-.905

-.722

-.855

.364

.643

.423

.899

.981

(1)

(2)

(3)

(4)

(5)

.185

-.848

.540

-.958

-.103

.201

-.090

-.329

.950

Public
Health
Expenditure
GDP
Female
School

.924

-.493

Enrolment
Urban
Population

Table 6: Simulation of Public Health Expenditure and Malaria Mortality for Ghana and
Nigeria
Variables

Ghana
(1)

Malaria
Mortality

Nigeria

(2)

(3)

(4)

(5)

-.867

-.905

-.722

-.855

.983

.918

1.000

.899

.981

(1)

(2)

(3)

(4)

(5)

-.963

-.848

.540

-.958

.942

-.501

1.000

-.329

.950

Public
Health
Expenditure
GDP
Female
School

.924

Enrolment
Urban
Population

26

-.493

Table 7: Public Health Expenditure and Infant Mortality for Ghana and Nigeria
Variables

Ghana
(1)

Infant
Mortality

Nigeria

(2)

(3)

(4)

(5)

-.422

-.983

-.920

-.999

.364

.643

.423

.899

.981

(1)

(2)

(3)

(4)

(5)

.048

-.982

.437

-.972

-.103

.201

-.090

-.329

.950

Public
Health
Expenditure
GDP
Female
School

.924

-.493

Enrolment
Urban
Population

Table 8: Simulated Public Health Expenditure and Infant Mortality for Ghana and Nigeria
Variables

Ghana
(1)

Infant
Mortality

Nigeria

(2)

(3)

(4)

(5)

-.999

-.983

-.920

-.999

.983

.918

1.000

.899

.981

(1)

(2)

(3)

(4)

(5)

-.967

-.982

.437

-.972

.942

-.501

1.000

-.329

.950

Public
Health
Expenditure
GDP
Female
School

.924

Enrolment
Urban
Population

27

-.493

Table 9: Public Health Expenditure and Maternal Mortality for Ghana and Nigeria
Variables

Ghana
(1)

Maternal
Mortality

Nigeria

(2)

(3)

(4)

(5)

-.550

-.834

-.866

-.912

.364

.643

.423

.899

.981

(1)

(2)

(3)

(4)

(5)

.076

-.966

.450

-.954

-.103

.201

-.090

-.329

.950

Public
Health
Expenditure
GDP
Female
School

.924

-.493

Enrolment
Urban
Population

Table 10: Simulated Public Health Expenditure and Maternal Mortality for Ghana and
Nigeria
Variables

Ghana
(1)

Maternal
Mortality

Nigeria

(2)

(3)

(4)

(5)

-.904

-.834

-.866

-.912

.983

.918

1.000

.899

.981

(1) (2)

-.948

(3)

(4)

(5)

-.966

.450

-.954

.942

-.501

1.000

-.329

.950

Public
Health
Expenditure
GDP
Female
School

.924

Enrolment
Urban
Population

28

-.493

The result of the health expenditure and health outcome relationship are presented in tables 3, 4,
5, 6, 7, 8, 9, and 10 above for HIV/AIDS mortality, malaria mortality, infant mortality and maternal
mortality. The results from the alternative specifications which was used to test the robustness of
the model are also reported in the tables. Tables 4, 5, 8, and 10, represents the simulated analysis
of the public health expenditure and health outcome relationship. The simulation is an assumption
that both countries implemented 15% public health expenditure budget as agreed in the United
Nations Assembly and the Abuja Declaration in the year1999 and 2000 respectively (Edeme,
Richardson, Emecheta, & Omeje, 2017).

Table 3 above, is a bivariate relationship between public health expenditure as a share of GDP and
HIV/AIDS mortality as a share of total deaths for Ghana and Nigeria. The relationship shows to
be negative for Ghana, although the effect of public health expenditure is not statistically
significant. The result implies that on the average, a percentage increase in public health
expenditure in Ghana, would reduce HIV/AIDS mortality by 0.1%. However, in the case of
Nigeria as seen in Table 3, contradicts the result in Ghana. The relationship between public health
expenditure and HIV/AIDS mortality in Nigeria appears to be positive. It implies that when public
health expenditure increases by 1%, HIV/AIDS mortality also increases by 0.3%. When controlled
by GDP, female school enrolment and urban population respectively, the result suggests that
increasing public health expenditure reduces HIV/AIDS deaths by approximately 0.9% in Ghana.
For Nigeria, the case remains the same (positive correlation). When public health expenditure was
assumed to maintain a 16.4% average between year 2000 and 2018 in both countries, the
relationship was negative in both countries, although the effect was more significant in Ghana than
Nigeria as seen in table 4. This simulation implies that the public health expenditure for both
countries are very low. Therefore, it lacks the strength to reduce HIV/AIDS mortality in
significantly. Secondly, out-of-pocket expenditure is very high in both countries and this may be
the likely be the reason for the improvement that we see in the trend analysis for both countries.
Thirdly, the findings suggest that attaining the 15% public health expenditure target pledged at UN
Assembly and Abuja Declaration in the years 1999 and 2000 respectively is critical to reducing
the burden of HIV/AIDS in both countries.
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In table 5, Public health expenditure showed a negative relationship with malaria deaths in Ghana
but not Nigeria. This suggests that increasing public health expenditure budget as a proportion of
GDP by 1% would reduce malaria deaths in Ghana by 0.063% which is very insignificant.
However, after controlling for other variables such as GDP, school enrolment, and urban
population, the result suggests that increasing public health expenditure by 1% significantly
reduces malaria deaths in Ghana by approximately 0.91%, 0.72%, and 0.9% respectively. This
case is also similar in Nigeria, however, only GDP and urban population were able to reduce
malaria mortality after increasing public health expenditure by 1%. After simulating that public
health expenditure was averaged 16.4% between 2000 and 2018 as seen in table 6, the relationship
between public health expenditure and malaria mortality negatively correlated, this is an
implication that public health is very low in both countries especially Nigeria. Hence, for any
significant impact to be observed both countries would have to increase public health expenditure
to at least 15% of the total government’s expenditure.

The infant mortality case for both countries is seen in table 7, the direct relation between public
health expenditure and infant mortality works with the existing theory for Ghana, although, when
controlled for GDP the relationship. Although, when controlled for GDP and urban population,
the relationship becomes negative in Nigeria. Increasing public expenditure based on the
simulations as seen in table 8 for Ghana and Nigeria reduces infant mortality rate in both countries,
without the use of control variables. However, controlling for these variables significantly reduces
the estimate. For example, in Nigeria, the infant mortality rate improves from -0.42% to 0.98%
when controlled before simulation, and after simulation, it improves from 0.97% to 0.98% after
controlling for GDP.

Table 9 represents the public health expenditure–maternal mortality relationship for Ghana and
Nigeria respectively. Yet again, the effect of public expenditure on maternal mortality showed a
negative relationship for Ghana, and positively related in Nigeria. However, controlling for other
variables (GDP and Urban population) indicated there was a significant effect of public health
expenditure on maternal mortality in Nigeria. For Ghana, the relationship between public health
expenditure and maternal mortality remains negative and statistically significant. While
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controlling for female school enrolment could not improve the relationship between public
expenditure and maternal mortality in Nigeria.

In summary, at first glance, the tables suggest different effect of public health expenditure on the
different health outcomes. One interesting reason might be because of the fact that in these
countries public health expenditure is very low and may not be well targeted at interventions or
infrastructure that address these concerns such as HIV/AIDS, malaria, infant and maternal
mortality. Secondly, another interesting reason might be the effect of out-of-pocket (OOP)
expenditure which seems to be very high in these countries. For instance, in Nigeria out-of-pocket
health expenditure accounts for 77.2% of total health expenditure in 2017 (World Bank Group,
2020). Thirdly, these two countries rely heavily on foreign aids, these may be another factor that
would affect these relationships. To check if these two factors (OOP and foreign aid) are actually
driving the inconsistencies in the relationship between public health expenditure and these health
outcomes, it will be important to see whether including out-of-pocket expenditure and foreign aid
provides a more robust regression estimate. Also, the large population of Nigeria estimated at 202
million people in 2019 (World Bank, 2020) may be a reason for the consistent variations observed
between Ghana and Nigeria in the results when compared to Ghana’s population of 29.6 million
people (World Bank, 2020).

4.5

Limitation

The only limitation experienced by this study was the availability of consistent data for out-ofpocket expenditure and foreign aids to examine if these two variables were responsible for the
improvement of the health outcomes over the period. Future studies can examine this relationship
incorporating OOP and foreign aids into the dataset depending on the data availability.

5.0

Conclusion

From the results of this study, it can be deduced that public health expenditure has the potential to
reduce health burdens like infant and maternal mortality, and malaria and HIV/AIDS mortality in
both Nigeria and Ghana. Although, the proportion of total government’s expenditure spent on
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healthcare in both countries is very low to combat infant, maternal, malaria and HIV/AIDS
mortalities. The simulation conducted by this study has revealed that increasing public health
expenditure significantly (at least 15%) can reduce health outcomes significantly. This study has
shown that fulfilling the UN Assembly (MDG/SDG) and the Abuja Declaration commitment is
critical to resolving this over dragging issues. Also, other factors like GDP and residing in urban
areas also determines prevalence of health outcomes. Many rural communities in low-and-middle
income countries like Nigeria and Ghana do not have access to health care facilities which is
critical for good health.

Several lessons can be could be deduced from the findings of this study. One of the lessons is the
statistical insignificance of public health expenditure as a percentage of GDP in improving health
outcomes in Ghana, and the positive relationship found in Nigeria. This suggests that, coupled
with the fact that public health expenditure is very low, and OOP is very high, government should
also concentrate on the redistributive role of income to bridge the income inequality gap that exists
between the rural and urban residents, in order to improve these burden health outcomes. Secondly,
taking a look at most high income and developed countries, technological advancement may also
be determining factor to significantly reducing the high mortalities caused by these outcomes. For
instance, after many years many Sub-Sahara African countries are still battling with the malaria
endemic.

Based on the results from this study, since budgetary allocations for healthcare has the power to
boost and enhance health outcomes, policy makers and the government of Nigeria and Ghana have
to pay massive attention to increasing and efficiently maximizing public health expenditures.
Following the requirements of the SDGs target to reduce infant and maternal mortality and the
eradication of malaria, improved domestic and foreign mobilization of resources would also be
critical for its achievement in Nigeria and Ghana, as well as other low-income countries struggling
with similar challenges.
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